Article
Genetic and Epigenetic Landscape for Drug Development in Polycystic Ovary Syndrome
31 Jan 2024
Abstract excerpt
The treatment of polycystic ovary syndrome (PCOS) faces challenges as all known treatments are merely symptomatic. The US Food and Drug Administration has not approved any drug specifically for treating PCOS. As the significance of genetics and epigenetics rises in drug development, their pivotal insights have greatly enhanced the efficacy and success of drug target discovery and validation, offering promise for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
